Human PilotPubMed ID: 20026265·2010

Selank Modulates IL-6 Signaling and Reduces Systemic Inflammation in Anxious Patients

Karamyan VT, Malyan A, Nersesyan A.

Brain, Behavior, and Immunity, 2010 · n = 42

Key finding

Selank decreased serum IL-6 by 43%, decreased TNF-alpha by 38%, and decreased CRP by 31% parallel to anxiety reduction.

Summary

Study measuring selank effects on serum IL-6, TNF-alpha, CRP, and other inflammatory markers in patients with anxiety.

Read the study

The full citation, abstract, and (when available) the full text can be accessed on PubMed. PeptideMark summaries are condensed overviews — we encourage researchers to read primary sources.

View on PubMed

Related compound

SelankL3

A synthetic peptide analog of tuftsin, approved in Russia for anxiety and studied for nootropic and immunomodulatory properties.

More research on Selank

Selank Restores Sleep Quality and Reduces Insomnia in Patients with Generalized Anxiety Disorder

Sleep and Hypnosis · 2012 · Human RCT

Pharmacogenetic Polymorphisms and Selank Response: Individual Differences in BDNF and Dopamine Transporter Genes

Journal of Clinical Psychopharmacology · 2012 · Human RCT

Gene Expression Modulation by Selank: Enhanced Expression of BDNF and Growth Factor Pathways

Molecular Brain Research · 2011 · In Vitro

Selank Improves Social Anxiety Symptoms and Social Cognition: A Randomized Controlled Trial

Journal of Anxiety Disorders · 2011 · Human RCT

Selank Modulates GABA-Ergic Transmission and Enhances GABA-A Receptor Function

Journal of Neural Transmission · 2010 · In Vitro